FI750488A - - Google Patents

Info

Publication number
FI750488A
FI750488A FI750488A FI750488A FI750488A FI 750488 A FI750488 A FI 750488A FI 750488 A FI750488 A FI 750488A FI 750488 A FI750488 A FI 750488A FI 750488 A FI750488 A FI 750488A
Authority
FI
Finland
Application number
FI750488A
Other languages
Finnish (fi)
Inventor
Joseph Hellerbach
Armin Walser
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH225569A external-priority patent/CH562220A5/xx
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of FI750488A publication Critical patent/FI750488A/fi

Links

FI750488A 1969-02-14 1975-02-21 FI750488A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH225569A CH562220A5 (es) 1969-02-14 1969-02-14
FI700400A FI49965C (fi) 1969-02-14 1970-02-13 Menetelmä terapeuttisesti käytettävien 1,3-dihydro-1-(metoksimetyyli)- 5-fenyyli-2H-1,4-bentsodiatsepiini-2-onien valmistamiseksi.

Publications (1)

Publication Number Publication Date
FI750488A true FI750488A (es) 1975-02-21

Family

ID=25689926

Family Applications (1)

Application Number Title Priority Date Filing Date
FI750488A FI750488A (es) 1969-02-14 1975-02-21

Country Status (1)

Country Link
FI (1) FI750488A (es)

Similar Documents

Publication Publication Date Title
AU2270770A (es)
AU465452B2 (es)
AU429630B2 (es)
AU450150B2 (es)
AU2355770A (es)
AU442375B2 (es)
AU470301B1 (es)
AU427401B2 (es)
AU442357B2 (es)
AU425297B2 (es)
AU417208B2 (es)
AU428074B2 (es)
AU428129B2 (es)
AU428131B2 (es)
AU414607B2 (es)
AU470661B1 (es)
AU438128B2 (es)
AT308690B (es)
AU442285B2 (es)
AU442322B2 (es)
AU442554B2 (es)
AU410358B2 (es)
AU442380B2 (es)
AU442463B2 (es)
AU442535B2 (es)

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: F HOFFMANN-LA ROCHE & CO. AG